Tropical Journal of Pharmaceutical Research
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
Vol. 15, No. 1, 2016, pp. 81-86
Bioline Code: pr16011
Full paper language: English
Document type: Research Article
Document available free of charge
Tropical Journal of Pharmaceutical Research, Vol. 15, No. 1, 2016, pp. 81-86
© Copyright 2016 - Tropical Journal of Pharmaceutical Research
Effect of Diallylsulphide Supplementation on Wistar Rats Exposed to Mercuric Chloride|
Ansar, S. & AlGhosoon, H. T.
Purpose: To evaluate the protective potential of diallylsulphide (DAS) against mercury-induced
oxidative stress and antioxidant enzymatic alterations in spleen of rats.
Methods: Rats were randomly divided into 4 groups of 6 rats each and exposed to mercuric chloride
(HgCl2) (50 mg/kg, i.p.) and/or diallylsulphide (200 mg/kg/b.w) by gavage. Oxidative stress was
evaluated in spleen by antioxidant markers, viz, lipid per oxidation (LPO), superoxide dismutase (SOD),
reduced glutathione (GSH), glutathione peroxidase (GPx) and catalase (CAT). Histomorphological
changes in the spleen of rats were also compared between groups.
Results: Oral administration of DAS at a concentration of 50 mg/kg daily showed a significant increase
in GSH and GPx (p < 0.05), SOD and CAT (p < 0.05), as well as decreased LPO (p < 0.05) level in the
spleen of rats as compared with HgCl2 treated rats. Histopathology of spleen also showed that
administration of DAS reduced the damage generated by HgCl2 treatment.
Conclusion: The results suggest that DAS may effectively normalize impaired antioxidant status in
HgCl2-induced oxidative stress. DAS has a protective effect against lipid peroxidation by scavenging
free radicals and is thus capable of ameliorating mercury-induced changes in the spleen of adult Wistar
Diallylsulphide; Metal toxicity; Antioxidants; Spleen; Mercury
Alternative site location: http://www.tjpr.org